Pfizer, BioNTech to supply Japan with 120 million doses of MRNA-based COVID-19 vaccine candidate
July 31, 2020 – Pfizer (New York, NY) and BioNTech SE (Germany) announced an agreement with the Ministry of Health, Labour and Welfare (MHLW) in…
BioNTech SE
Pfizer, BioNTech granted FDA Fast Track designation for two investigational MRNA-based vaccine candidates for SARS-COV-2
Pfizer, Biontech granted FDA Fast Track designation for two investigational MRNA-based vaccine candidates for SARS-COV-2